Highlights:
– One-year results show DESTINY of drug elution below the knee
– ACE trialists conclude that EVAR offer no benefit over open repair at five years
– Two new lower profile EVAR devices launched at ESVS
– Drug coated balloons continue to show early promise
[pdfviewer width=”100%” height=”940px” beta=”true”]https://vascularnews.com/wp-content/uploads/sites/7/2016/02/48-Vascular-News_low-res.pdf[/pdfviewer]
